• Je něco špatně v tomto záznamu ?

Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris

D. Holmannova, P. Borsky, L. Borska, C. Andrys, K. Hamakova, V. Rehacek, T. Svadlakova, A. Malkova, M. Beranek, V. Palicka, J. Krejsek, Z. Fiala

. 2020 ; 21 (16) : . [pub] 20200805

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012286

Grantová podpora
Q40-09 Charles University, Faculty of Medicine in Hradec Kralove, the Czech Republic
Q40-10 Charles University, Faculty of Medicine in Hradec Kralove, the Czech Republic
Q40-11 Charles University, Faculty of Medicine in Hradec Kralove, the Czech Republic
SVV-260543/2020 Charles University, Faculty of Medicine in Hradec Kralove, the Czech Republic

BACKGROUND: Psoriasis is a pathological condition characterized by immune system dysfunction and inflammation. Patients with psoriasis are more likely to develop a wide range of disorders associated with inflammation. Serum levels of various substances and their combinations have been associated with the presence of the disease (psoriasis) and have shown the potential to reflect its activity. The aim of the present study is to contribute to the elucidation of pathophysiological links between psoriasis, its pro-inflammatory comorbidity metabolic syndrome (MetS), and the expression of clusterin and elafin, which are reflected in the pathophysiological "portfolio" of both diseases. MATERIAL AND METHODS: Clinical examinations (PASI score), ELISA (clusterin, elafin), and biochemical analyses (parameters of MetS) were performed. RESULTS: We found that patients with psoriasis were more often afflicted by MetS, compared to the healthy controls. Clusterin and elafin levels were higher in the patients than in the controls but did not correlate to the severity of psoriasis. CONCLUSION: Our data suggest that patients with psoriasis are more susceptible to developing other systemic inflammatory diseases, such as MetS. The levels of clusterin and elafin, which are tightly linked to inflammation, were significantly increased in the patients, compared to the controls, but the presence of MetS in patients did not further increase these levels.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012286
003      
CZ-PrNML
005      
20220124084028.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21165617 $2 doi
035    __
$a (PubMed)32764517
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Holmannova, Drahomira $u Institute of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50038 Hradec Kralove, Czech Republic
245    10
$a Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris / $c D. Holmannova, P. Borsky, L. Borska, C. Andrys, K. Hamakova, V. Rehacek, T. Svadlakova, A. Malkova, M. Beranek, V. Palicka, J. Krejsek, Z. Fiala
520    9_
$a BACKGROUND: Psoriasis is a pathological condition characterized by immune system dysfunction and inflammation. Patients with psoriasis are more likely to develop a wide range of disorders associated with inflammation. Serum levels of various substances and their combinations have been associated with the presence of the disease (psoriasis) and have shown the potential to reflect its activity. The aim of the present study is to contribute to the elucidation of pathophysiological links between psoriasis, its pro-inflammatory comorbidity metabolic syndrome (MetS), and the expression of clusterin and elafin, which are reflected in the pathophysiological "portfolio" of both diseases. MATERIAL AND METHODS: Clinical examinations (PASI score), ELISA (clusterin, elafin), and biochemical analyses (parameters of MetS) were performed. RESULTS: We found that patients with psoriasis were more often afflicted by MetS, compared to the healthy controls. Clusterin and elafin levels were higher in the patients than in the controls but did not correlate to the severity of psoriasis. CONCLUSION: Our data suggest that patients with psoriasis are more susceptible to developing other systemic inflammatory diseases, such as MetS. The levels of clusterin and elafin, which are tightly linked to inflammation, were significantly increased in the patients, compared to the controls, but the presence of MetS in patients did not further increase these levels.
650    _2
$a dospělí $7 D000328
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a klusterin $x genetika $7 D051152
650    _2
$a komorbidita $7 D015897
650    _2
$a elafin $x genetika $7 D053492
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese $x genetika $7 D005786
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x genetika $x metabolismus $x patologie $7 D007249
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metabolický syndrom $x komplikace $x genetika $x metabolismus $x patologie $7 D024821
650    _2
$a lidé středního věku $7 D008875
650    _2
$a psoriáza $x komplikace $x genetika $x metabolismus $x patologie $7 D011565
650    _2
$a stupeň závažnosti nemoci $7 D012720
655    _2
$a časopisecké články $7 D016428
700    1_
$a Borský, Pavel, $u Institute of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50038 Hradec Kralove, Czech Republic ; Institute of Pathological Physiology, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $d 1992- $7 xx0268728
700    1_
$a Borska, Lenka $u Institute of Pathological Physiology, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic
700    1_
$a Andrys, Ctirad $u Institute of Clinical Immunology and Allergology, University Hospital and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic
700    1_
$a Hamakova, Kvetoslava $u Clinic of Dermatology and Venereology, University Hospital Hradec Kralove, 50005 Hradec Králové, Czech Republic
700    1_
$a Rehacek, Vit $u Transfusion Center, University Hospital, 50005 Hradec Kralove, Czech Republic
700    1_
$a Švadláková, Tereza $u Institute of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50038 Hradec Kralove, Czech Republic ; Institute of Clinical Immunology and Allergology, University Hospital and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic $7 xx0268729
700    1_
$a Malkova, Andrea $u Institute of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50038 Hradec Kralove, Czech Republic
700    1_
$a Beranek, Martin $u Institute of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50038 Hradec Kralove, Czech Republic ; Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic
700    1_
$a Palicka, Vladimir $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic
700    1_
$a Krejsek, Jan $u Institute of Clinical Immunology and Allergology, University Hospital and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic
700    1_
$a Fiala, Zdenek $u Institute of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50038 Hradec Kralove, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 16 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32764517 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20220124084029 $b ABA008
999    __
$a ok $b bmc $g 1650616 $s 1132665
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 16 $e 20200805 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a Q40-09 $p Charles University, Faculty of Medicine in Hradec Kralove, the Czech Republic
GRA    __
$a Q40-10 $p Charles University, Faculty of Medicine in Hradec Kralove, the Czech Republic
GRA    __
$a Q40-11 $p Charles University, Faculty of Medicine in Hradec Kralove, the Czech Republic
GRA    __
$a SVV-260543/2020 $p Charles University, Faculty of Medicine in Hradec Kralove, the Czech Republic
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace